Celebrating haematology research in Germany

22 September 2020
22 September 2020

We are delighted to share a selection of haematology content from researchers across Germany covering all aspects of haematology. All content is published open access so it is freely available for the global research community to read and reuse. This has been made possible by funding from Projekt DEAL as part of a nationally coordinated strategy to enable a large scale transition of today's scholarly journals to open access in Germany.

Export Citation(s)Download PDF(s)

Table of Contents

Open Access

The time to relapse correlates with the histopathological growth pattern in nodular lymphocyte predominant Hodgkin lymphoma

Sylvia Hartmann,  Annette Plütschow,  Anja Mottok,  Heinz-Wolfram Bernd,  Alfred C. Feller,  German Ott,  Sergio Cogliatti,  Falko Fend,  Leticia Quintanilla-Martinez,  Harald Stein,  Wolfram Klapper,  Peter Möller,  Andreas Rosenwald,  Andreas Engert,  Martin-Leo Hansmann,  Dennis A. Eichenauer, 
Open Access

Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma: 2-year follow-up of the CHRONOS-1 study

Martin Dreyling,  Armando Santoro,  Luigina Mollica,  Sirpa Leppä,  George Follows,  Georg Lenz,  Won Seog Kim,  Arnon Nagler,  Maria Dimou,  Judit Demeter,  Muhit Özcan,  Marina Kosinova,  Krimo Bouabdallah,  Franck Morschhauser,  Don A. Stevens,  David Trevarthen,  Javier Munoz,  Liana Rodrigues,  Florian Hiemeyer,  Ashok Miriyala,  Jose Garcia-Vargas,  Barrett H. Childs,  Pier Luigi Zinzani, 
Open Access

Therapeutic plasma exchange in acute liver failure

Klaus Stahl,  Johannes Hadem,  Andrea Schneider,  Michael P. Manns,  Olaf Wiesner,  Bernhard M. W. Schmidt,  Marius M. Hoeper,  Markus Busch,  Sascha David, 
Open Access

Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01/2010 Study

Halet Türkantoz,  Christoph Königs,  Paul Knöbl,  Robert Klamroth,  Katharina Holstein,  Angela Huth-Kühne,  Jürgen Heinz,  Hermann Eichler,  Andreas Tiede, 
Open Access

Sex-specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry

Stefano Barco,  Frederikus A. Klok,  Stavros V. Konstantinides,  Philippe Dartevelle,  Elie Fadel,  David Jenkins,  Nick H. Kim,  Michael Madani,  Hiromi Matsubara,  Eckhard Mayer,  Joanna Pepke-Zaba,  Gérald Simonneau,  Marion Delcroix,  Irene M. Lang, 
Open Access

Clinical evaluation of bleeds and response to haemostatic treatment in patients with acquired haemophilia: A global expert consensus statement

Andreas Tiede,  Paul Giangrande,  Jerome Teitel,  Kagehiro Amano,  Gary Benson,  László Nemes,  Victor Jiménez-Yuste,  Roseline d'Oiron,  Soraya Benchikh El Fegoun,  Craig M. Kessler, 
Open Access

Individual combinations of danger signals synergistically increase FVIII product immunogenicity

Lilija Miller,  Jessica Klemm,  Carolin Schmidt,  Kay-Martin Hanschmann,  Isabelle Bekeredjian-Ding,  Zoe Waibler, 
Open Access

Transfusion in limited infrastructure locations – where to go decades after safe blood initiative by World Health Organization?

Angela Ugwu,  Dalha Gwarzo,  Theresa Nwagha,  Aisha Gwarzo,  Andreas Greinacher, 
Open Access

Molecular basis of human neutrophil antigen 2 (HNA-2) expression

Behnaz Bayat, 
Open Access

Evaluation of the Atellica COAG 360 coagulation analyzer in a central laboratory of a maximum care hospital

Sebastian Hörber,  Rainer Lehmann,  Andreas Peter, 
Open Access

Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature

Phil-Robin Tepasse,  Wali Hafezi,  Mathias Lutz,  Joachim Kühn,  Christian Wilms,  Rainer Wiewrodt,  Jan Sackarnd,  Martin Keller,  Hartmut H. Schmidt,  Richard Vollenberg, 
Open Access

Risk stratification and prognostic biomarkers in relapsed Hodgkin lymphoma

Paul J. Bröckelmann,  Bastian von Tresckow, 
Open Access

Differences in treatment and monitoring of chronic myeloid leukemia with regard to age, but not sex: Results from a population-based study

Michael Lauseker,  Roman Gerlach,  Wenke Worseg,  Torsten Haferlach,  Martin Tauscher,  Joerg Hasford,  Verena S. Hoffmann, 
Open Access

Inhibition of PLK1 by capped-dose volasertib exerts substantial efficacy in MDS and sAML while sparing healthy haematopoiesis

Veronika Dill,  Johanna Kauschinger,  Richard T. Hauch,  Lars Buschhorn,  Timo O. Odinius,  Catharina Müller-Thomas,  Ritu Mishra,  Michele C. Kyncl,  Burkhard Schmidt,  Peter M. Prodinger,  Dirk Hempel,  Frauke Bellos,  Alexander Höllein,  Wolfgang Kern,  Torsten Haferlach,  Julia Slotta-Huspenina,  Florian Bassermann,  Christian Peschel,  Katharina S. Götze,  Irene C. Waizenegger,  Ulrike Höckendorf,  Philipp J. Jost,  Stefanie Jilg,